ORIGINAL ARTICLE |
|
Year : 2016 | Volume
: 10
| Issue : 3 | Page : 97-101 |
|
Pure tone audiometric findings in patients on second-line treatment for multidrug-resistant tuberculosis
Matilda Uju Ibekwe, Chibuike Nwosu
Department of ENT Surgery, University of Port Harcourt Teaching Hospital, Port Harcourt, Rivers State, Nigeria
Correspondence Address:
Matilda Uju Ibekwe Department of ENT Surgery, University of Port Harcourt Teaching Hospital, Port Harcourt, Rivers State Nigeria
Source of Support: None, Conflict of Interest: None | Check |
DOI: 10.4103/0795-3038.197748
|
|
Background: The need for second-line antitubercular medication has been on the increase due to the emergence of multidrug-resistant strain tuberculosis (MDR-TB) in our environment.
Aim: This study was to assess the effect of second-line antitubercular medication on hearing in patients with MDR-TB.
Patients and Methods: This is a prospective study of all the patients admitted to the MDR-TB center of the University of Port Harcourt Teaching Hospital between January and May 2013. All patients had pure tone audiometry done before and 3 months after commencement of second-line antitubercular medications. The second-line regimen used includes kanamycin, levofloxacin, cycloserine, pyrazinamide, and pyridoxine.
Results: The study had a total of 28 patients. There were 14 males and 14 females. The age range was between 18 and 68 years. Different degrees of high-frequency sensorineural hearing loss (SNHL) were seen in 14 patients after 3 months' therapy. There were 13 bilateral and 1 unilateral hearing impairment, 2 patients had profound SNHL. However, a good number had involvement of the speech frequencies.
Conclusion: Second-line antitubercular medication appears to have a tremendous effect on hearing. This raises a public health issue since there is a growing increase in MDR-TB in our environment. |
|
|
|
[FULL TEXT] [PDF]* |
|
|
|